564
Participants
Start Date
May 10, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
ofatumumab
There is no treatment allocation. Patients administered ofatumumab by prescription that have started as routine medical treatment will be enrolled.
glatiramer acetate
There is no treatment allocation. Patients administered glatiramer acetate by prescription that have started as routine medical treatment will be enrolled.
interferon β1
There is no treatment allocation. Patients administered interferon β1 by prescription that have started as routine medical treatment will be enrolled.
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Rüdersdorf
Novartis Investigative Site, Neuruppin
Novartis Investigative Site, Rostock
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Altenholz
Novartis Investigative Site, Wildeshausen
Novartis Investigative Site, Bremen
Novartis Investigative Site, Hanover
Novartis Investigative Site, Hanover
Novartis Investigative Site, Hanover
Novartis Investigative Site, Minden
Novartis Investigative Site, Marburg
Novartis Investigative Site, Marburg
Novartis Investigative Site, Gladenbach
Novartis Investigative Site, Giessen
Novartis Investigative Site, Fulda
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Meerbusch
Novartis Investigative Site, Mettmann
Novartis Investigative Site, Remscheid
Novartis Investigative Site, Dortmund
Novartis Investigative Site, Lünen
Novartis Investigative Site, Bochum
Novartis Investigative Site, Bochum
Novartis Investigative Site, Essen
Novartis Investigative Site, Essen
Novartis Investigative Site, Gelsenkirchen
Novartis Investigative Site, Münster
Novartis Investigative Site, Osnabrück
Novartis Investigative Site, Cologne
Novartis Investigative Site, Bergneustadt
Novartis Investigative Site, Bonn
Novartis Investigative Site, Trier
Novartis Investigative Site, Alzey
Novartis Investigative Site, Montabaur
Novartis Investigative Site, Siegen
Novartis Investigative Site, Hagen
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Bad Homburg
Novartis Investigative Site, Erbach im Odenwald
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Mannheim
Novartis Investigative Site, Saalouis
Novartis Investigative Site, Kaiserslautern
Novartis Investigative Site, Schwetzingen
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Böblingen
Novartis Investigative Site, Weil der Stadt
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Nagold
Novartis Investigative Site, Hettingen
Novartis Investigative Site, Schwaebisch
Novartis Investigative Site, Pforzheim
Novartis Investigative Site, Karlsruhe
Novartis Investigative Site, Rülzheim
Novartis Investigative Site, München
Novartis Investigative Site, München
Novartis Investigative Site, Unterhaching
Novartis Investigative Site, Neuburg an der Donau
Novartis Investigative Site, Untermeiting
Novartis Investigative Site, Dillingen
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Bayreuth
Novartis Investigative Site, Bamberg
Novartis Investigative Site, Bamberg
Novartis Investigative Site, Erfurt
Novartis Investigative Site, Mühlhausen
Novartis Investigative Site, Berlin
Novartis Investigative Site, Altenburg
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Dessau
Novartis Investigative Site, Dresden
Novartis Investigative Site, Dresden
Novartis Investigative Site, Halle
Novartis Investigative Site, Jena
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Stadtroda
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY